tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:2105 Stock Latest News

Laekna, Inc. Partners with Qilu Pharma for Exclusive Licensing of LAE002 in China
Company AnnouncementsLaekna, Inc. Partners with Qilu Pharma for Exclusive Licensing of LAE002 in China
28d ago
2105
Laekna, Inc. Advances Breast Cancer Treatment with Promising Clinical Study
PremiumCompany Announcements
Laekna, Inc. Advances Breast Cancer Treatment with Promising Clinical Study
1M ago
2105
Laekna, Inc. Advances Obesity Treatment with LAE102 Study
PremiumCompany Announcements
Laekna, Inc. Advances Obesity Treatment with LAE102 Study
1M ago
2105
Laekna, Inc. Reports Positive Phase I Results for Obesity Treatment
PremiumCompany Announcements
Laekna, Inc. Reports Positive Phase I Results for Obesity Treatment
2M ago
2105
Laekna, Inc. Completes Successful Share Placement to Boost R&D
PremiumCompany Announcements
Laekna, Inc. Completes Successful Share Placement to Boost R&D
3M ago
2105
Laekna, Inc. Advances Obesity Treatment with Promising Clinical Trial Results
PremiumCompany AnnouncementsLaekna, Inc. Advances Obesity Treatment with Promising Clinical Trial Results
4M ago
2105
Laekna, Inc. Secures FDA Approval for New Metabolic Disease Therapy
Premium
Company Announcements
Laekna, Inc. Secures FDA Approval for New Metabolic Disease Therapy
4M ago
2105
Laekna, Inc. Schedules Board Meeting to Review Interim Results
Premium
Company Announcements
Laekna, Inc. Schedules Board Meeting to Review Interim Results
4M ago
2105
Laekna, Inc. Advances LAE103 with FDA Application
PremiumCompany Announcements
Laekna, Inc. Advances LAE103 with FDA Application
5M ago
2105
Laekna, Inc. Unveils Promising Study Results at ADA 2025
PremiumCompany Announcements
Laekna, Inc. Unveils Promising Study Results at ADA 2025
6M ago
2105
Laekna, Inc. Successfully Concludes Annual General Meeting with All Resolutions Passed
PremiumCompany Announcements
Laekna, Inc. Successfully Concludes Annual General Meeting with All Resolutions Passed
6M ago
2105
Laekna, Inc. Announces Annual General Meeting and Key Resolutions
PremiumCompany Announcements
Laekna, Inc. Announces Annual General Meeting and Key Resolutions
7M ago
2105
Laekna, Inc. Grants 11.46 Million RSUs to Boost Executive and Employee Engagement
PremiumCompany AnnouncementsLaekna, Inc. Grants 11.46 Million RSUs to Boost Executive and Employee Engagement
7M ago
2105
Laekna, Inc. Advances Obesity Drug LAE102 with U.S. FDA Submission
Premium
Company Announcements
Laekna, Inc. Advances Obesity Drug LAE102 with U.S. FDA Submission
8M ago
2105
Laekna, Inc. Advances Obesity Treatment with LAE102 Study
Premium
Company Announcements
Laekna, Inc. Advances Obesity Treatment with LAE102 Study
9M ago
2105
Laekna, Inc. Schedules Board Meeting to Approve Annual Results
PremiumCompany Announcements
Laekna, Inc. Schedules Board Meeting to Approve Annual Results
9M ago
2105
Laekna Completes Phase I Study of Obesity Drug LAE102 with Positive Results
PremiumCompany Announcements
Laekna Completes Phase I Study of Obesity Drug LAE102 with Positive Results
11M ago
2105
Laekna Advances Obesity Treatment with LAE102 Trials
PremiumCompany Announcements
Laekna Advances Obesity Treatment with LAE102 Trials
1y ago
2105
Laekna, Inc. Advances LAE123 for Severe Diseases
PremiumCompany Announcements
Laekna, Inc. Advances LAE123 for Severe Diseases
1y ago
2105
Laekna, Inc. Raises HK$230 Million Through Share Placement
PremiumCompany AnnouncementsLaekna, Inc. Raises HK$230 Million Through Share Placement
1y ago
2105
Laekna, Inc. Announces Share Placement to Raise HK$230 Million
Premium
Company Announcements
Laekna, Inc. Announces Share Placement to Raise HK$230 Million
1y ago
2105
Laekna Partners with Eli Lilly on Obesity Drug Development
Premium
Company Announcements
Laekna Partners with Eli Lilly on Obesity Drug Development
1y ago
2105

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >